Albumin
Active ingredient description
Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10% of the protein synthesis activity of the liver. The most important physiological functions of albumin results from its contribution to oncotic pressure of the blood and transport function. Albumin stabilises circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Medicines
Albumin is the active ingredient of these drugs:
Hong Kong
Austria Brazil Cyprus Hong Kong Poland
United States
Cyprus Finland Hong Kong Netherlands
Brazil
Cyprus
Hong Kong New Zealand Singapore
United States
Tunisia
United States
New Zealand
Austria Cyprus Ecuador Estonia Finland
Spain
Austria Brazil Canada Cyprus Finland
Ecuador Hong Kong United States
Hong Kong Ireland Poland Singapore Spain
Brazil
Brazil
Austria Estonia Poland
United States
Austria Cyprus Estonia Hong Kong Ireland
Poland
United States
Brazil Canada New Zealand
Canada Cyprus Hong Kong Singapore Spain
Hong Kong Singapore United States
United States
Singapore
Brazil France Hong Kong Tunisia
France Hong Kong Tunisia
Cyprus Singapore United Kingdom
United Kingdom
Product monographs
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):
3D molecular structure
Unique ingredient identifier (UNII)
ZIF514RVZR - ALBUMIN HUMAN
CAS registry number
9006-50-2 - Egg white
SNOMED-CT
52454007 - Albumin (substance)